A Controlled, Randomized-Blinded Clinical Trial to Assess the Efficacy of a Nitric Oxide Releasing Patch in the Treatment of Cutaneous Leishmaniasis by Leishmania (V.) panamensis

ABSTRACT: A topical nanofiber nitric oxide (NO) releasing patch (≈3.5 μmol NO/cm2/day for 20 days, NOP) was compared with intramuscular meglumine antimoniate (Glucantime, 20 mg/kg/day for 20 days) for the treatment of cutaneous leishmaniasis (CL) caused by Leishmania (V.) panamensis in Santander and...

Full description

Autores:

López Jaramillo, Patricio
Rincón Acelas, Melvin Yesid
García Gómez, Ronal Guillermo
Silva, Sandra Y
Smith, Erin
Kampeerapappun, Piyaporn
García, Carlos
Vélez Bernal, Iván Darío
López, Marcos

Tipo de recurso:

Article of investigation

Fecha de publicación:

2010

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/21295

Acceso en línea:

http://hdl.handle.net/10495/21295

Palabra clave:

Óxido Nítrico
Nitric Oxide
Ensayo Clínico Controlado
Controlled Clinical Trial
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Leishmania
Antimoniato de Meglumina
Meglumine Antimoniate

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/